# EDGAR Filing Document

**Accession Number:** 0001872302
**File Stem:** 0001213900-25-088368
**Filing Date:** 2025-9
**Character Count:** 111609
**Document Hash:** 08451cbfe6a5c5da93b7bcb4fef5b280
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-088368.hdr.sgml**: 20250917

**ACCESSION NUMBER**: 0001213900-25-088368

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 87

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250917

**DATE AS OF CHANGE**: 20250917

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nano Labs Ltd
- **CENTRAL INDEX KEY:** 0001872302
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41426
- **FILM NUMBER:** 251318824

**BUSINESS ADDRESS:**
- **STREET 1:** 30 FLOOR, DICARA SILVER CENTER
- **STREET 2:** NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT
- **CITY:** HANGZHOU
- **STATE:** F4
- **ZIP:** 310000
- **BUSINESS PHONE:** 8615968976786

**MAIL ADDRESS:**
- **STREET 1:** 30 FLOOR, DICARA SILVER CENTER
- **STREET 2:** NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT
- **CITY:** HANGZHOU
- **STATE:** F4
- **ZIP:** 310000

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16 UNDER**

**THE SECURITIES EXCHANGE ACT OF 1934**

For the month of September 2025

Commission File Number: 001-41426

**Nano Labs Ltd**

(Exact name of registrant as specified in its charter)

China Yuangu Hanggang Technology Building

509 Qianjiang Road, Shangcheng District,

Hangzhou, Zhejiang, 310000

People's Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F ☐

**EXPLANATORY NOTE**

The documents attached as exhibits 99.1 and 99.2 to this Form 6-K are hereby incorporated by reference into the registrant's Registration Statements on (1) [Form F-3](http://www.sec.gov/Archives/edgar/data/1872302/000119312523212289/d466253df3.htm) initially filed with the U.S. Securities and Exchange Commission (the "Commission") on August 14, 2023 (Registration No. 333-273968), (2) [Form F-3](https://www.sec.gov/Archives/edgar/data/1872302/000121390025062186/ea0248074-f3_nano.htm), as amended, initially filed with the Commission on July 9, 2025 (Registration No. 333-288573), and (3) [Form F-3](https://www.sec.gov/Archives/edgar/data/1872302/000121390025071307/ea0250751-f3_nano.htm), as amended, initially filed with the Commission on August 4, 2025 (Registration No. 333-289211), and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Nano Labs Ltd** | **Nano Labs Ltd** |
| Date: September 17, 2025 | By: | /s/ Jianping Kong |
|  | Name: | Jianping Kong |
|  | Title: | Chairman and Chief Executive Officer |

---

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| Exhibit 99.1 | [Unaudited Consolidated Financial Statements as of December 31, 2024 and June 30, 2025 and for the six months ended June 30, 2024 and 202<u>5</u>](ea025544701ex99-1_nano.htm) |
| Exhibit 99.2 | [Management's Discussion and Analysis of Financial Condition and Results of Operations](ea025544701ex99-2_nano.htm) |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |

---

## Exhibit 99.1

?xml version='1.0' encoding='ASCII'?

**Exhibit 99.1**

**NANO LABS LTD**

**CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

---

| | | | |
|:---|:---|:---|:---|
|  | | **As of <br> June 30,** | **As of <br> June 30,** |
|  | **As of<br> December 31,**<br>**2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
| **ASSETS** |  |  |  |
| **Current assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 32431081 | 363440412 | 50769761 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 418722 | 468526 | 65449 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 572803 | 507688 | 70920 |
| &nbsp;&nbsp;&nbsp;Inventories, net | 29866418 | 35850932 | 5008093 |
| &nbsp;&nbsp;&nbsp;Prepayments | 4606066 | 8652263 | 1208653 |
| &nbsp;&nbsp;&nbsp;Cryptocurrencies | 242889085 | 776702624 | 108499235 |
| &nbsp;&nbsp;&nbsp;Other current assets | 55858433 | 52122427 | 7281092 |
| **Total current assets** | 366642608 | 1237744872 | 172903203 |
| **Non-current assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Long-term investment |  | 2000000 | 279384 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 197341915 | 188159300 | 26284372 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | 46745444 | 46252522 | 6461113 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 5203525 | 3572268 | 499018 |
| **Total non-current assets** | 249290884 | 239984090 | 33523887 |
| **TOTAL ASSETS** | 615933492 | 1477728962 | 206427090 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |  |
| **Current liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Short-term debts | 18000000 | 33000000 | 4609840 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debts | 5350000 | 6120000 | 854916 |
| &nbsp;&nbsp;&nbsp;Convertible notes denominated in Bitcoin |  | 470948166 | 65787747 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 18101451 | 23204810 | 3241529 |
| &nbsp;&nbsp;&nbsp;Advance from customers | 98895905 | 95626084 | 13358210 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities, current | 1914109 | 1019231 | 142379 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 67163217 | 53026502 | 7407384 |
| **Total current liabilities** | 209424682 | 682944793 | 95402005 |
| **Non-current liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Long-term debts | 170683636 | 173479763 | 24233756 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities, non-current | 2917350 | 2222688 | 310492 |
| **Total non-current liabilities** | 173600986 | 175702451 | 24544248 |
| **Total liabilities** | 383025668 | 858647244 | 119946253 |
| **Shareholders' equity:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Class A ordinary shares ($0.002 par value; 14,141,093 and 1,097,141,091 shares authorized as of December 31, 2024 and June 30, 2025, respectively; 13,273,596 and 20,712,924 shares issued as of December 31, 2024 and June 30, 2025, respectively; 12,815,143 and 20,258,282 shares outstanding as of December 31, 2024 and June 30, 2025, respectively) | 176842 | 283472 | 39599 |
| &nbsp;&nbsp;&nbsp;Class B ordinary shares ($0.002 par value; 2,858,909 shares authorized; 2,858,909 shares issued and outstanding as of December 31, 2024 and June 30, 2025) | 36894 | 36894 | 5154 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 780499664 | 1180185753 | 164862648 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (565218741) | (572273282) | (79942067) |
| &nbsp;&nbsp;&nbsp;Statutory reserves | 6647109 | 6647109 | 928549 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 8647353 | 6805404 | 950661 |
| **Total Nano Labs Ltd shareholders' equity** | 230789121 | 621685350 | 86844544 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interests | 2118703 | (2603632) | (363707) |
| **Total shareholders' equity** | 232907824 | 619081718 | 86480837 |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | 615933492 | 1477728962 | 206427090 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements

**NANO LABS LTD**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)**

**(Unaudited)**

---

| | | | |
|:---|:---|:---|:---|
|  | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** |
|  | **2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
| **Net revenues** | 24739480 | 8283373 | 1157122 |
| **Cost of revenues** | 24709417 | 18991737 | 2652996 |
| **Gross profit (loss)** | 30063 | (10708364) | (1495874) |
| **Operating expenses:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing expenses | 4334564 | 2617584 | 365656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 25453212 | 21544148 | 3009548 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 28934228 | 3163558 | 441924 |
| **Total operating expenses** | 58722004 | 27325290 | 3817128 |
| **Loss from operations** | (58691941) | (38033654) | (5313002) |
| **Other expenses (income):** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finance expenses (income) | (607804) | 274189 | 38302 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expenses | 2009586 | 5287620 | 738639 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income | (96679) | (12322) | (1721) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of cryptocurrencies |  | (48610295) | (6790475) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of convertible notes |  | 18529435 | 2588416 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income | (851374) | (1724344) | (240877) |
| **Total other expenses (income)** | (453729) | (26255717) | (3667716) |
| **Loss before income tax provision** | (59145670) | (11777937) | (1645286) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax provision |  |  |  |
| **Net loss** | (59145670) | (11777937) | (1645286) |
| **Less: net loss attributable to noncontrolling interests** | (1911930) | (4723396) | (659821) |
| **Net loss attributable to Nano Labs Ltd** | (57233740) | (7054541) | (985465) |
| **Comprehensive income (loss):** |  |  |  |
| Net loss | (59145670) | (11777937) | (1645286) |
| Other comprehensive income: |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 4800723 | (1840888) | (257158) |
| **Total comprehensive loss** | (54344947) | (13618825) | (1902444) |
| **Comprehensive loss attributable to noncontrolling interests** | (1912013) | (4722335) | (659673) |
| **Comprehensive loss attributable to Nano Labs Ltd** | (52432934) | (8896490) | (1242771) |
| **Net loss per ordinary share attributable to Nano Labs Ltd** |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic\* | (8.46) | (0.43) | (0.06) |
| &nbsp;&nbsp;&nbsp;Diluted\* | (8.46) | (0.43) | (0.06) |
| **Weighted average number of shares used in per share calculation:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic\* | 6766671 | 16548783 | 16548783 |
| &nbsp;&nbsp;&nbsp;Diluted\* | 6766671 | 16548783 | 16548783 |

---

\* After giving effect of the 10-for-1 reverse stock split effective on November 3, 2024, see Note 12.

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**NANO LABS LTD**

**CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)**

**(Unaudited)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A<br> Ordinary Share** | **Class A<br> Ordinary Share** | **Class B<br> Ordinary Shares** | **Class B<br> Ordinary Shares** | | | | | | |
|  | **Number of<br> Shares\*** | **Amount** | **Number of<br> Shares\*** | **Amount** | **Additional**<br>**Paid—in<br> Capital** |<br>**Statutory<br> Reserves** |<br>**Accumulated<br> Deficit** | **Accumulated<br> Other**<br>**Comprehensive <br> Income** |<br>**Noncontrolling <br> Interest** | **Total<br> Shareholders'**<br>**Equity<br> (Deficit)** |
|  | | **RMB** | | **RMB** | **RMB** | **RMB** | **RMB** | **RMB** | **RMB** | **RMB** |
| **Balance, January 1, 2024** | 3724236 | 50106 | 2858909 | 36894 | 428310028 | 6647109 | (452031693) | 2254558 | (1528352) | (16261350) |
| &nbsp;&nbsp;&nbsp;Issuance of ordinary shares and warrants, net of issuance costs | 434783 | 6176 |  |  | 30604069 |  |  |  |  | 30610245 |
| &nbsp;&nbsp;&nbsp;Cash contribution from a noncontrolling shareholder |  |  |  |  |  |  |  |  | 9999557 | 9999557 |
| &nbsp;&nbsp;&nbsp;Share—based compensation |  |  |  |  | 285507 |  |  |  |  | 285507 |
| &nbsp;&nbsp;&nbsp;Issuance of ordinary shares upon the exercise of stock options | 8185 | 116 |  |  |  |  |  |  |  | 116 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (57233740) |  | (1911930) | (59145670) |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment |  |  |  |  |  |  |  | 4800806 | (83) | 4800723 |
| **Balance, June 30, 2024** | 4167204 | 56398 | 2858909 | 36894 | 459199604 | 6647109 | (509265433) | 7055364 | 6559192 | (29710872) |
| **Balance, January 1, 2025** | 12815143 | 176842 | 2858909 | 36894 | 780499664 | 6647109 | (565218741) | 8647353 | 2118703 | 232907824 |
| Issuance of ordinary shares and warrants in cash, net of issuance costs | 5952381 | 85272 |  |  | 330401650 |  |  |  |  | 330486922 |
| Issuance of ordinary shares upon the exercise of warrants | 573233 | 8218 |  |  | 26545198 |  |  |  |  | 26553416 |
| Issuance of ordinary shares upon the exercise of stock options | 3811 |  |  |  |  |  |  |  |  |  |
| Issuance of ordinary shares in exchange for cryptocurrencies, net of issuance costs | 913714 | 13140 |  |  | 42417624 |  |  |  |  | 42430764 |
| Cash contribution from a shareholder |  |  |  |  | 259280 |  |  |  |  | 259280 |
| Share—based compensation |  |  |  |  | 62337 |  |  |  |  | 62337 |
| Net loss |  |  |  |  |  |  | (7054541) |  | (4723396) | (11777937) |
| Foreign currency translation adjustment |  |  |  |  |  |  |  | (1841949) | 1061 | (1840888) |
| **Balance, June 30, 2025** | 20258282 | 283472 | 2858909 | 36894 | 1180185753 | 6647109 | (572273282) | 6805404 | (2603632) | 619081718 |
| **Balance, June 30, 2025 in US$** | 20258282 | 39599 | 2858909 | 5154 | 164862648 | 928549 | (79942067) | 950661 | (363707) | 86480837 |

---

\* After giving effect of the 10-for-1 reverse stock split effective on November 3, 2024, see Note 12.

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**NANO LABS LTD**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | | |
|:---|:---|:---|:---|
|  | **For the six months ended <br> June 30,** | **For the six months ended <br> June 30,** | **For the six months ended <br> June 30,** |
|  | **2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
| **Cash flows from operating activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | (59145670) | (11777937) | (1645286) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | 2209489 | 718621 | 100386 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expenses | 3240245 | 5521626 | 771328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on disposal of property, plant and equipment |  | (26938) | (3763) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on lease termination | 68454 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 285507 | 62337 | 8708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory write-down | 12395993 | 5726162 | 799900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of cryptocurrencies |  | (48610295) | (6790475) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of convertible notes |  | 18529435 | 2588416 |
| &nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 1258245 | 64099 | 8954 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | (8289134) | (11716340) | (1636680) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepayments | 617643 | (4120749) | (575636) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | (10876189) | 4210499 | 588174 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 1237849 | 6021654 | 841177 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance from customers | (6671941) | (3262245) | (455710) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (2315354) | (676904) | (94558) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | (10769483) | (11445588) | (1598858) |
| Net cash used in operating activities | (76754346) | (50782563) | (7093923) |
| **Cash flows from investing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (32935838) | (597910) | (83523) |
| &nbsp;&nbsp;&nbsp;Proceeds from disposal of property, plant and equipment |  | 2088051 | 291684 |
| &nbsp;&nbsp;&nbsp;Purchase of investment |  | (2000000) | (279384) |
| &nbsp;&nbsp;&nbsp;Proceeds from disposal of cryptocurrencies |  | 7895941 | 1103001 |
| Net cash provided by (used in) investing activities | (32935838) | 7386082 | 1031778 |
| **Cash flows from financing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of ordinary shares and warrants | 30610245 | 357040338 | 49875721 |
| &nbsp;&nbsp;&nbsp;Cash contribution from a shareholder |  | 259280 | 36219 |
| &nbsp;&nbsp;&nbsp;Cash contribution from a noncontrolling shareholder | 9999557 |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from bank loans | 185306916 | 21216127 | 2963726 |
| &nbsp;&nbsp;&nbsp;Repayments of bank loans | (145737636) | (2650000) | (370184) |
| Net cash provided by financing activities | 80179082 | 375865745 | 52505482 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | 4853211 | (1410129) | (196986) |
| **Net increase (decrease) in cash, cash equivalents and restricted cash** | (24657891) | 331059135 | 46246351 |
| **Cash, cash equivalents and restricted cash at beginning of the period** | 48582654 | 32849803 | 4588859 |
| **Cash, cash equivalents and restricted cash at end of the period** | 23924763 | 363908938 | 50835210 |
| **Supplemental cash flow disclosures:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest paid | 4485989 | 5287620 | 738639 |
| &nbsp;&nbsp;&nbsp;Income taxes paid | 165278 |  |  |
| **Non-cash investing and financing activities:** |  |  |  |
| Operating lease right-of-use asset obtained in exchange for operating lease liability | 1927067 | 912636 | 127488 |
| Cryptocurrencies acquired through issuance of ordinary shares |  | 42430764 | 5927243 |
| Cryptocurrencies acquired through issuance of convertible notes |  | 454084117 | 63431972 |
| Payment of expense in the form of cryptocurrencies |  | 490482 | 68516 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statement.

**NANO LABS LTD**

**NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS**

**(all amounts in RMB, except share or as otherwise noted)**

**1. Organization and nature of operations**

Nano Labs Ltd ("Nano Labs"), incorporated on January 8, 2021, is a holding company, as an exempted company with limited liability in the Cayman Islands. Nano Labs principally engages in fabless integrated circuit ("IC") design and sale of product solutions by integrating its self-designed IC products. The Company started cryptocurrency value investment business at the end of 2024.

Prior to the incorporation of the Company, the Company's business was carried out by Zhejiang Haowei Technology Co., Ltd. ("Zhejiang Haowei") and its subsidiaries. Zhejiang Haowei was established by Mr. Jianping Kong, the principal shareholder, chairman and chief executive officer, in July 2019. Nano Labs underwent a series of onshore and offshore reorganizations, which were completed in September 2021 (the "Reorganization").

Immediately before and after the Reorganization, the controlling shareholders of Zhejiang Haowei controlled Zhejiang Haowei and Nano Labs; therefore, for accounting purposes, the Reorganization is accounted for as a transaction of entities under common control. Accordingly, the accompanying unaudited consolidated financial statements have been prepared as if the current corporate structure had been in existence throughout the periods presented.

The Company does not conduct any substantive operations on its own but instead conducts its business operations through its subsidiaries. The Company's major subsidiaries are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name of subsidiaries** | **Date of<br> incorporation** | **Place of<br> incorporation** | **Ownership<br> percentage** | **Principal<br> activities** |
| Zhejiang Haowei Technology Co., Ltd. ("Zhejiang Haowei") | July 16, 2019 | Hangzhou, China | 100% | Research and development of ICs |
| Zhejiang Nanomicro Technology Co., Ltd. ("Zhejiang Nanomicro") | July 16, 2019 | Hangzhou, China | 100% | Research and development of ICs |
| Zhejiang NanoBlock Technology Co., Ltd. | July 16, 2019 | Hangzhou, China | 100% | Research and development of ICs |
| Zhejiang Ipollo Technology Co., Ltd. | August 18, 2020 | Hangzhou, China | 100% | Distribution of products |
| Nano Labs HK Limited | September 8, 2020 | Hong Kong | 100% | Investment |
| Nano Labs Inc | December 22, 2020 | BVI | 100% | Investment |
| Zhejiang Weike Technology Co., Ltd. ("Zhejiang Weike") | June 2, 2021 | Hangzhou, China | 100% | Research and development of software |
| Ipollo Tech Inc | June 29, 2021 | BVI | 100% | Investment |
| Nano Technology HK Limited | July 7, 2021 | Hong Kong | 100% | Investment |
| Ipollo HK Limited | July 7, 2021 | Hong Kong | 100% | Distribution of products |
| Zhejiang Metaverse Technology Co., Ltd. | August 12, 2021 | Hangzhou, China | 100% | Investment |
| Ipollo Tech Ltd | October 27, 2021 | Cayman | 100% | Investment |
| Haowei Technology (Shaoxing) Co., Ltd. | November 3, 2021 | Shaoxing, China | 100% | Investment |
| Shenzhen Matamata Technology Co., Ltd. | November 17, 2021 | Shenzhen, China | 100% | Distribution of products |
| Nano bit HK Limited (formerly Tsuki HK Limited） | November 18, 2021 | Hong Kong | 100% | Investment |
| Tsuki Inc | January 7, 2022 | United States | 100% | Distribution of products |
| Metaski (Shaoxing) Technology Co., Ltd. | January 13, 2022 | Shaoxing, China | 100% | Distribution of products |
| Haoweiverse (Shaoxing) Technology Co., Ltd. ("Haoweiverse") | January 13, 2022 | Shaoxing, China | 65% | Plant and distribution of products |
| Metameta (Shaoxing) Technology Co., Ltd. | January 25, 2022 | Shaoxing, China | 100% | Distribution of products |
| Ipolloverse HK Limited | May 18, 2022 | Hong Kong | 70% | Research and development |
| Metaverse (Shaoxing) Technology Co., Ltd. | May 20, 2022 | Shaoxing, China | 100% | Distribution of products |
| Ipolloverse Cayman Ltd | May 27, 2022 | Cayman | 70% | Investment |
| Ipolloverse Tech Inc | May 30, 2022 | BVI | 70% | Investment |
| Hangzhou Meta Technology Co., Ltd. | October 21, 2022 | Hangzhou, China | 100% | Distribution of products |

---

Nano Labs and its consolidated subsidiaries are collectively referred to herein as the "Company", "we" and "us", unless specific reference is made to an entity.

**2. Summary of Significant Accounting Policies** 

***Basis of preparation***

The unaudited consolidated financial statements of the Company have been prepared in accordance with the accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for the complete consolidated financial statements. The unaudited consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments as necessary for the fair statement of the Company's financial position as of June 30, 2025, results of operations and cash flows for the six months ended June 30, 2024 and 2025. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related footnotes thereto contained in the Company's most recent consolidated annual financial statements filed with the SEC on Form 20-F. Results for the six months ended June 30, 2025 are not necessarily indicative of the results expected for the full fiscal year or for any future period.

***Use of estimates***

The preparation of the Company's unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant accounting estimates reflected in the Company's unaudited consolidated financial statements include, but not limited to, inventory write-down, valuation of cryptocurrencies, valuation of convertible notes denominated in Bitcoin, useful lives of property, plant and equipment and intangible assets, impairment of long-lived assets, valuation allowance for deferred tax assets and share-based compensation.

***Principles of consolidation***

The Company's unaudited consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.

***Functional currency and foreign currency translation***

The Company uses Renminbi ("RMB") as its reporting currency. The functional currency of the Company and its subsidiaries incorporated outside of the People's Republic of China ("PRC") is the United States dollar ("US$"), while the functional currency of the PRC entities in the Company is RMB as determined based on the criteria of ASC 830, "*Foreign Currency Matters"*.

Transactions denominated in other than the functional currencies are re-measured into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are re-measured at the balance sheet date exchange rate. The resulting exchange differences are included in the unaudited consolidated statements of operations and comprehensive income (loss).

The financial statements of the Company are translated from the functional currency to the reporting currency, RMB. Assets and liabilities of the Company and its subsidiaries incorporated outside of PRC are translated into RMB at fiscal year-end exchange rates. Income and expense items are translated at average exchange rates prevailing during the fiscal year, representing the index rates stipulated by the People's Bank of China. Translation adjustments arising from these are reported as foreign currency translation adjustments and are shown as a separate component of shareholders' equity (deficit) on the unaudited consolidated financial statement.

***Convenience translation***

The United States dollar ("US$") amounts disclosed in the accompanying financial statements are presented solely for the convenience of the readers. Translations of amounts from RMB into US$ were calculated at the rate of US$1.00=RMB7.1586 on June 30, 2025, representing the central parity rate on June 30, 2025 published by the People's Bank of China. No representation is made that the RMB amounts could have been, or could be, converted into US$ at that rate on June 30, 2025, or at any other rate.

***Concentration of credit risk***

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents with financial institutions with high credit ratings and quality.

***Fair value measurement***

The Company adopted the guidance of Accounting Standards Codification ("ASC") 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Observable, market-based inputs, other than quoted prices, in active markets for similar assets or liabilities.

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

ASC 820 also describes three main approaches to measuring the fair value of assets and liabilities:

(1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.

As of December 31, 2024 and June 30, 2025, the carrying values of current assets and current liabilities approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments, except for cryptocurrencies and convertible notes denominated in bitcoins.

Assets measured at fair value on a recurring basis as of December 31, 2024 and June 30, 2025 are summarized as below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Fair Value Measurements as of December 31, 2024** | **Fair Value Measurements as of December 31, 2024** | **Fair Value Measurements as of December 31, 2024** | **Fair Value Measurements as of December 31, 2024** | **Fair Value Measurements as of December 31, 2024** |
|  | **Quoted Prices**<br> **in Active**<br> **Markets for**<br> **Identical**<br> **Assets** <br> **(Level 1)** | **Significant**<br> **Other**<br> **Observable**<br> **Inputs**<br> **(Level 2)** | **Unobservable<br> Inputs** <br> **(Level 3)** | **Fair value**<br> **at December 31,**<br> **2024** |
|  | **RMB** | **RMB** | **RMB** | **RMB** |
| Cryptocurrencies | 776702624 |  |  | 776702624 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Fair Value Measurements as of June 30, 2025** | **Fair Value Measurements as of June 30, 2025** | **Fair Value Measurements as of June 30, 2025** | **Fair Value Measurements as of June 30, 2025** | **Fair Value Measurements as of June 30, 2025** |
|  | **Quoted Prices**<br> **in Active**<br> **Markets for**<br> **Identical**<br> **Assets** <br> **(Level 1)** | **Significant**<br> **Other**<br> **Observable**<br> **Inputs**<br> **(Level 2)** | **Unobservable<br> Inputs** <br> **(Level 3)** | **Fair value**<br> **at April 30,**<br> **2025** |
|  | **RMB** | **RMB** | **RMB** | **RMB** |
| Cryptocurrencies | 242889085 |  |  | 242889085 |
| Convertible notes denominated in bitcoin |  | 470948166 |  | 470948166 |

---

***Related party transactions***

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Parties are also considered to be related if they are subject to common control or common significant influence. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Related parties may be individuals or corporate entities.

Transactions involving related parties cannot be presumed to be carried out on an arm's-length basis, as the requisite conditions of competitive, free market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm's-length transactions unless such representations can be substantiated. It is not, however, practical to determine the fair value of amounts due from/to related parties due to their related party nature.

***Cash and cash equivalents***

Cash and cash equivalents include cash in bank and time deposits placed with banks or other financial institutions, which have original maturities of three months or less and are readily convertible to known amounts of cash. As of December 31, 2024 and June 30, 2025, cash and cash equivalents in banks was RMB32,431,081 and RMB363,440,412, respectively.

***Restricted cash***

Restricted cash mainly represents the bank deposit frozen by the court as a result of legal proceedings. As of December 31, 2024 and June 30, 2025, the Company had restricted cash balance of RMB 418,722 and RMB 468,526, respectively.

***Inventories, net***

Inventories, consist of raw materials, work in process and finished goods. Inventories are stated at the lower of cost and net realizable value. Cost of inventory is determined using the weighted average cost method. Adjustments are recorded to write down the cost of inventory to the estimated net realizable value due to slow-moving and obsolete inventory, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment.

***Cryptocurrencies***

Cryptocurrencies are included in current assets in the consolidated balance sheets due to the Company's ability to sell cryptocurrencies in a highly liquid marketplace, and such cryptocurrency holdings are expected to be realized in cash or sold or consumed during the normal operating cycle of the Company.

As a result of adopting ASC 350-60, Intangibles — Goodwill and Other, ("ASC 350-60") on January 31, 2024 following modified retrospective method, cryptocurrencies are measured at fair value as of each reporting period. The fair value of cryptocurrencies are measured using the period-end closing price from the principal market, Binance, in accordance with ASC 820, Fair Value Measurement ("ASC 820"). The changes in cryptocurrencies valuation due to remeasurement in fair value within each reporting period are reflected on the consolidated statements of operations and comprehensive income (loss) as "Change in fair value of cryptocurrencies". In accordance with ASC 350-60, the Company discloses realized gains and losses from the sale of cryptocurrencies and such gains and losses are measured as the difference between the cash proceeds and the cost basis of cryptocurrencies as determined using average cost method.

Cryptocurrencies acquired through issuance of ordinary shares and convertible notes are included within noncash financing activities in the consolidated statements of cash flows. The purchases and disposals of cryptocurrencies are included within investing activities in the consolidated statements of cash flows.

***Property, plant and equipment, net***

Property, plant and equipment are stated at historical cost less accumulated depreciation and impairment loss, if any. Depreciation is calculated using the straight-line method over their estimated useful lives. The estimated useful lives are as follows:

---

| | |
|:---|:---|
| Machinery and electronic equipment | 3 to 10 years |
| Office furniture | 5 years |
| Transportation equipment | 4 years |
| Buildings and facilities attached to buildings | 20 years |

---

Leasehold improvements are depreciated using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term.

***Intangible assets, net***

The Company's intangible assets with definite useful lives primarily consist of a franchise right and land use right. According to the law of PRC, the government owns all the land in the PRC. Companies or individuals are authorized to possess and use the land only through land use rights granted by the Chinese government for a specified period of time. The Company amortizes its franchise right and land use right on a straight-line basis over the contractual term. The estimated useful lives are as follows:

Franchise right 2 years <br> Land use right 50 years

***Impairment of long-lived assets***

For long-lived assets including property, plant and equipment, right-of-use assets, and intangible assets with finite lives, the Company evaluates for impairment whenever events or changes (triggering events) indicate that the carrying amount of an asset may no longer be recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset's estimated fair value and its book value. For the six months ended June 30, 2024 and 2025, no impairment of long-lived assets was recognized.

***Convertible notes denominated in bitcoin***

The Company issues non-interest-bearing convertible notes denominated in Bitcoin that can be converted into Class A ordinary shares of the Company at the option of the holder at any time point by the maturity date, which is 360 days from the issuance date. The conversion price is fixed in US$ amount, and the number of shares issued is subject to the Bitcoin price quoted on Hashkey Exchange on the date of conversion request. The convertible note is accounted for as hybrid instrument with a debt host contract and embedded derivatives linked to the fair value of Bitcoins and the Company's stock prices. The Company measures this hybrid instrument at fair value through the election of fair value option. Election of the fair value option is generally irrevocable unless an event occurs that gives rise to a new basis of accounting for that instrument. The gain or loss from change in fair value of convertible notes are reported as a separate caption in other expenses (income) on the consolidated statements of operations and comprehensive income (loss).

The fair value of the convertible notes denominated in bitcoin was measured using Monte Carlo simulation model. The significant inputs used in the Monte Carlo simulation model include stock price, bitcoin price, expected volatility of stock price and bitcoin price, term, and risk-free interest rate.

***Revenue from contracts with customers***

Consistent with the criteria of ASC 606 "Revenue from Contracts with Customers", the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to receive in exchange for those goods or services. Revenue consists of the invoiced value for the sales net of value-added tax ("VAT"), business tax and applicable local government levies.

*Product sales revenue*

The Company generates revenue primarily from the sale of product solutions by integrating its self-designed IC products (e.g., high throughput computing, or HTC, solutions) directly to a customer, such as a business or individual engaged in mining activities.

The Company recognizes revenue at a point in time when the control of the products has been transferred to customers. The transfer of control is considered complete when products have been picked up by or shipped to customers. The Company's sales arrangements usually require prepayment before the delivery of products. The advance payment is not considered a significant financing component. The Company elected to account for shipping and handling fees as a fulfillment cost. The product sales contracts generally include product warranty provisions. The Company did not accrue warranty liabilities for the product sales as the financial impacts of the warranty have historically been and are expected to continue to be immaterial. The Company estimates sales return based on historical experiences and there was no allowance for sales return recorded during the six months ended June 30, 2024 and 2025.

*Service revenue*

The Company also generates revenue from its design and technical services under separate contracts. Revenues from the design and technical service to the customers are recognized at a point in time when services are provided.

*Revenue disaggregation*

In accordance with ASC 606, the Company disaggregates revenue from contracts with customers by revenue stream. The Company determined that disaggregating revenue into these categories meets the disclosure objective in ASC 606 which is to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by regional economic factors. The following table summarizes the net revenues generated from different revenue streams:

---

| | | |
|:---|:---|:---|
|  | **For the six months ended<br> June 30,** | **For the six months ended<br> June 30,** |
|  | **2024** | **2025** |
|  | **(Unaudited)<br> RMB** | **(Unaudited)<br> RMB** |
| Product sales revenue | 20352715 | 7931032 |
| Service revenue | 4386765 | 352341 |
| **Net revenues** | 24739480 | 8283373 |

---

*Contract liabilities*

 

Contract liabilities are recorded when consideration is received from a customer prior to transferring the control of goods or services to the customer. As of December 31, 2024 and June 30, 2025, the Company recorded contract liabilities of RMB98,895,905 and RMB95,626,084, respectively, which were presented as advance from customers on the accompanying unaudited consolidated balance sheets. During the six months ended June 30, 2024 and 2025, the Company recognized RMB12,066,145 and RMB2,481,345 from the opening balance of contract liabilities as revenue, respectively.

***Cost of revenues***

Amounts recorded as cost of revenue relate to direct expenses incurred in order to generate revenue. Such costs are recorded as incurred. Cost of revenues consists of product costs and service costs. Product costs include costs of raw material, contract manufacturers for production, shipping and handling costs, warehousing costs, slow-moving and obsolete inventories write-downs, prepayments write-downs, and value-added tax recoverable write-downs. Service costs include labor costs and material costs. During the six months ended June 30, 2024 and 2025, the Company recorded inventory write-down of RMB12,395,993 and RMB 5,726,162 as cost of revenues, respectively.

***Selling and marketing expenses***

Selling and marketing expenses consist primarily of advertising and promotion, salaries, and shipping and handling costs incurred during the selling activities. Advertising and transportation expenses are charged to expense as incurred.

Advertising and promotion costs in the amounts of RMB245,883 and RMB650,802 for the six months ended June 30, 2024 and 2025, respectively, are included in selling and marketing expenses.

Shipping and handling costs amounting to RMB226,046 and RMB67,285 for the six months ended June 30, 2024 and 2025, respectively, are included in selling and marketing expenses.

***Research and development expenses***

Research and development expenses consist primarily of salary and welfare for research and development personnel, raw materials used, consulting and contractor expenses, testing and processing expenses and other expenses in associated with research and development activities. The Company recognizes research and development expenses as expense when incurred.

***Leases***

Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease.

The Company elected not to record assets and liabilities on its unaudited consolidated balance sheet for lease arrangements with terms of 12 months or less. The Company recognizes lease expenses for such leases on a straight-line basis over the lease term.

***Employee social security and welfare benefits***

Employees of the Company in the PRC are entitled to staff welfare benefits including pension, work-related injury benefits, maternity insurance, medical insurance, unemployment benefit and housing fund plans through a PRC government-mandated multi-employer defined contribution plan. The Company is required to contribute to the plan based on certain percentages of the employees' salaries, up to a maximum amount specified by the local government.

The PRC government is responsible for the medical benefits and the pension liability to be paid to these employees and the Company's obligations are limited to the amounts contributed and no legal obligation beyond the contributions made.

***Share-based compensation***

Restricted shares and options granted to employees and directors are accounted for under ASC Topic 718, "Compensation - Stock compensation" ("ASC 718"). In accordance with ASC 718, the Company determines whether restricted shares or options should be classified and accounted for as an equity award. All grants of restricted shares and options to employees and directors classified as equity awards are recognized in the financial statements based on their grant date fair values. The value of the portion of the award that is ultimately expected to vest is recognized as compensation expense over the requisite service periods in the statements of operations. In addition, compensation expense must be recognized for the change in fair value of any awards modified, repurchased or cancelled after the grant date.

The fair value of stock options granted is estimated on the grant date using the Binomial or Black-Scholes model.

***Income taxes***

The Company accounts for income taxes under the asset and liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax income rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded if it is more likely than not that some portion or all of the deferred income tax assets will not be realized in the foreseeable future.

In accordance with the provisions of ASC 740, "Income taxes", the Company recognizes in its financial statements the impact of a tax position if a tax return position or future tax position is "more likely than not" to be sustained upon examination based solely on the technical merits of the position. Tax positions that meet the recognition threshold are measured using a cumulative probability approach, at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. Interest and penalties arising from underpayment of income taxes are computed in accordance with the applicable tax law and is classified in the unaudited consolidated statements of operations as income tax expense.

***Noncontrolling interests***

For the Company's consolidated subsidiaries, noncontrolling interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder. Noncontrolling interests are classified as a separate line item in the equity section of the Company's unaudited consolidated balance sheets and have been separately disclosed in the Company's unaudited consolidated statements of operations and comprehensive income (loss).

***Comprehensive income (loss)***

Comprehensive income (loss) is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments from shareholders and distributions to shareholders. Comprehensive income (loss) for the periods presented includes net income (loss) and foreign currency translation adjustments.

***Earnings (loss) per share***

The Company computes earnings (loss) per share in accordance with ASC 260, "Earnings per Share". ASC 260 requires companies to present basic and diluted earnings (loss) per share. Basic earnings (loss) per share is computed by dividing net income (loss) attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings (loss) per share is calculated by dividing net income (loss) attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the period. Dilutive equivalent shares are excluded from the computation of diluted earnings (loss) per share if their effects would be anti-dilutive. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company's ordinary shares issuable upon the conversion of the share-based awards, using the treasury stock method.

***Segment Reporting***

The Company uses the "management approach" in determining reportable segments. The management approach considers the internal organization and reporting used by the Company's chief operating decision maker ("CODM") for making operating decisions and assessing performance as the source for determining the Company's reportable segments. The Company's CODM has been identified as the chief executive officer of the Company who reviews financial information of operating segments based on U.S. GAAP. The CODM now reviews results analyzed by marketing channel. This analysis is only presented at the revenue level with no allocation of direct or indirect costs. Consequently, the Company has determined that it has only one operating segment. The CODM evaluates performance for the Company's single operating segment and decides how to allocate resources based on the Company's consolidated net income (loss) that is reported in the consolidated statements of operations and comprehensive income (loss) as net income. As of December 31, 2024 and June 30, 2025, substantially all of the Company's long-lived assets are located in the PRC. The measure of segment assets is reported on the consolidated balance sheets as total assets. The CODM allocates resources across the Company based on consolidated net income derived during the annual budgeting process and throughout the year in monitoring actual results compared to budget and updated forecasts. These results are used to assess segment performance.

The operating segment financial information regularly reviewed by the CODM, inclusive assets, revenues, expenses, profit or loss, and noncash items are presented on a consolidated basis in the same amount and using the same captions as those included in the consolidated statements of operations and comprehensive income (loss), consolidated balance sheets, and consolidated statements of cash flows. There are no additional segment expense categories regularly provided to the CODM. Therefore, there are also no amounts classified as other segment items requiring disclosure.

For the six months ended June 30, 2024 and 2025, the Company's net revenues by geographical location of customers are as follows:

---

| | | |
|:---|:---|:---|
|  | **For the six months ended <br> June 30,** | **For the six months ended <br> June 30,** |
|  | **2024** | **2025** |
|  | **(Unaudited)** | **(Unaudited)** |
|  | **RMB** | **RMB** |
| PRC | 20059137 | 5462221 |
| The United States | 1019596 | 946288 |
| Singapore | 3409737 |  |
| Hong Kong |  | 1249900 |
| Others | 251010 | 624964 |
| **Net revenues** | 24739480 | 8283373 |

---

***Recently adopted or issued accounting pronouncements***

In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvement to Income Tax Disclosures" to enhance the transparency and decision usefulness of income tax disclosures, primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for annual periods beginning after December 15, 2024, on a prospective basis. Early adoption is permitted. The Company adopted ASU No. 2023-09 on January 1, 2025, which did not have a material impact on the consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosure (Subtopic 220-40): Disaggregation of Income Statement Expenses", requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU No. 2024-03.

**3. Inventories, net**

Inventories, net consist of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of<br> December 31,<br> 2024** | **As of<br> December 31,<br> 2024** | **As of <br> June 30,<br> 2025** | **As of <br> June 30,<br> 2025** |
|  | | | **(Unaudited)** | **(Unaudited)** |
|  | **RMB** | **RMB** | **RMB** | **RMB** |
| Raw materials |  | 11064697 |  | 4373715 |
| Work in process |  | 9979114 |  | 27861392 |
| Finished goods |  | 8822607 |  | 3615825 |
| Inventories, net | | 29,866,418 | | 35,850,932 |

---

**4. Prepayments**

Prepayments consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of<br> December 31, <br> 2024** | **As of<br> June 30,<br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Prepayments – inventories and processing fee | 3011819 | 6610361 |
| Prepayments – others | 1594247 | 2041902 |
| Prepayments | 4606066 | 8652263 |

---

**5. Other current assets**

Other current assets consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of<br> December 31, <br> 2024** | **As of<br> June 30,<br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Value-added tax recoverable | 50830552 | 47115730 |
| Deposits | 2202904 | 2497874 |
| Others | 2824977 | 2508823 |
| Total | 55858433 | 52122427 |

---

**6.** **Cryptocurrencies**

The following table presents the Company's significant cryptocurrencies holdings as of June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **Quantity** | **Cost Basis** | **Fair Value** |
| Bitcoin | 1000 | 740385593 | 770387447 |
| USDT | 882180 | 6337509 | 6315177 |
| **Total cryptocurrencies held as of June 30, 2025** |  | 746723102 | 776702624 |

---

**7. Property, plant and equipment, net**

Property, plant and equipment, net consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of<br> December 31,<br> 2024** | **As of<br> June 30,<br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Cost: |  |  |
| Machinery and electronic equipment | 17409218 | 14733245 |
| Office furniture | 370667 | 370966 |
| Leasehold improvement | 2794450 | 2794450 |
| Transportation equipment | 41014 | 41014 |
| Buildings and facilities attached to buildings | 194892201 | 192785765 |
| Less: Accumulated depreciation | (18165635) | (22568140) |
| Property, plant and equipment, net | 197341915 | 188159300 |

---

Depreciation expenses recognized for the six months ended June 30, 2024 and 2025 were RMB2,747,323 and RMB5,028,704, respectively.

As of December 31, 2024 and June 30, 2025, property, plant and equipment with net book value of RMB188,432,414 and RMB181,819,264 was pledged as collateral under a loan arrangement, respectively (also see Note 11).

**8. Intangible assets, net**

Intangible assets, net consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of<br> December 31,<br> 2024** | **As of<br> June 30,<br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Land use right | 49292208 | 49292208 |
| Franchise right | 334865 | 334865 |
| Less: Accumulated amortization | (2881629) | (3374551) |
| Intangible assets, net | 46745444 | 46252522 |

---

Amortization expense for the six months ended June 30, 2024 and 2025 amounted to RMB492,922 and RMB492,922, respectively.

As of December 31, 2024 and June 30, 2025, land use right with net book value of RMB46,745,444 and RMB46,252,522 was pledged as collateral under a loan arrangement, respectively (also see Note 11).

As of June 30, 2025, the future estimated amortization expenses are as below.

---

| | |
|:---|:---|
| **Years ended December 31,** | **Estimated<br> amortization <br> expense** |
|  | **(Unaudited)** |
|  | **RMB** |
| Remaining of 2025 | 492922 |
| 2026 | 985844 |
| 2027 | 985844 |
| 2028 | 985844 |
| 2029 | 985844 |
| Thereafter | 41816224 |
| Total | 46252522 |

---

**9. Operating leases**

The Company entered into various operating lease agreements for offices space. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The following component of lease cost are included in the Company's unaudited consolidated statements of operations and comprehensive income (loss):

---

| | | |
|:---|:---|:---|
|  | **For the<br> six months<br> ended<br> June 30,<br> 2024** | **For the <br> six months <br> ended<br> June 30,<br> 2025** |
|  | **(Unaudited)<br> RMB** | **(Unaudited)<br> RMB** |
| Operating lease cost | 2413523 | 722427 |
| Short-term lease cost | 363912 | 45425 |
| Total lease cost | 2777435 | 767852 |

---

Supplemental disclosure related to operating leases were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the <br> six months<br> ended<br> June 30,<br> 2024** | **For the <br> six months<br> ended<br> June 30,<br> 2024** | **For the<br> six months<br> ended <br> June 30,<br> 2025** | **For the<br> six months<br> ended <br> June 30,<br> 2025** |
|  | **(Unaudited)<br> RMB** | **(Unaudited)<br> RMB** | **(Unaudited)<br> RMB** | **(Unaudited)<br> RMB** |
| Cash paid for amounts included in the measurement of lease liabilities | | | | |
| Operating cash flows for operating leases |  | 2459231 |  | 771553 |

---

---

| | | |
|:---|:---|:---|
|  | **As of<br> December 31, <br> 2024** | **As of<br> June 30,<br> 2025** |
|  | | **(Unaudited)** |
| Weighted average remaining lease term of operating leases (years) | 3.26 | 3.33 |
| Weighted average discount rate of operating leases | 6.24% | 6.24% |

---

The following table summarizes the maturity of operating lease liabilities as of June 30, 2025:

---

| | |
|:---|:---|
| **Years Ended December 31,** | **Lease<br> Payment** |
|  | **(Unaudited)** |
|  | **RMB** |
| Remaining of 2025 | 592272 |
| 2026 | 1194360 |
| 2027 | 1197632 |
| 2028 | 602089 |
| Thereafter |  |
| Total lease payments | 3586353 |
| Less: imputed interest | (344434) |
| Total lease liabilities | 3241919 |
| Less: current portion | (1019231) |
| Non-current lease liabilities | 2222688 |

---

**10. Other current liabilities**

Other current liabilities consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of <br> December 31,<br> 2024** | **As of <br> June 30, <br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Salary accrual | 4001104 | 988326 |
| Deposit | 150303 | 121136 |
| Payable for property, plant and equipment | 26521368 | 19235697 |
| Tax accrual | 16173063 | 14615471 |
| Customer refund liabilities | 14471474 | 14471474 |
| Others | 5845905 | 3594398 |
| Total | 67163217 | 53026502 |

---

**11. Short-term and long-term debts**

Short-term debts

Starting from September 2023, the Company entered into multiple short-term loan agreements with Hangzhou United Rural Commercial Bank Co., Ltd., for working capital and general business purposes. As of June 30, 2025, the loans bear a weighted average interest rate of 3.4% and weighted average years to maturity of 0.42 year. During the six months ended June 30, 2024 and 2025, the Company borrowed nil and RMB15,000,000, and repaid nil, respectively. The guaranty information of the Company's outstanding short-term loans as of December 31, 2024 and June 30, 2025 consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of <br> December 31,<br> 2024** | **As of <br> June 30, <br> 2025** |
|  | | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Guaranteed by Mr. Jianping Kong, the principal shareholder, chairman and chief executive officer, Mr. Qifeng Sun, the principal shareholder and vice chairman, and two subsidiaries within the Company's organizational structure | 18000000 | 18000000 |
| Guaranteed by Mr. Jianping Kong and one subsidiary within the Company's organizational structure |  | 5000000 |
| Guaranteed by the Mr. Jianping Kong, one subsidiary within the Company's organizational structure, and a third party financial institution |  | 10000000 |

---

Long-term debts

On August 11, 2022, the Company entered into a line of credit agreement with Zhejiang Shaoxing Ruifeng Rural Commercial Bank for a credit line up to RMB100,000,000 with a due date on July 25, 2030. In June 2023, the credit line was increased to a maximum amount of RMB148,000,000, with guarantee provided by Mr. Jianping Kong starting from July 2023. In April 2024, the credit line was increased to a maximum amount of RMB198,000,000, with additional pledge by the Company's property, plant and equipment. During the six months ended June 30, 2024 and 2025, the Company borrowed RMB185,306,916 and RMB6,216,727 under the credit line and repaid RMB145,737,636 and RMB2,650,000, respectively. The outstanding loans bear an annual interest rate of 5.4% with repayment dates for parts of the loan ranging from December 20, 2025 to July 25, 2030. The loans are pledged by the property, plant and equipment and land use right of the Company (mentioned in Note 7 and Note 8).

As of June 30, 2025, the future maturities of long-term debts are as below:

---

| | |
|:---|:---|
| **Years Ended December 31,** | **Principal Repayment** |
|  | **(Unaudited)** |
|  | **RMB** |
| Remaining of 2025 | 2700000 |
| 2026 | 6890000 |
| 2027 | 8430000 |
| 2028 | 9970000 |
| 2029 | 11510000 |
| Thereafter | 140099763 |
| Total | 179599763 |

---

**12. Shareholders' equity (deficit)**

On October 23, 2024, the shareholders of the Company approved a 10-for-1 reverse stock split ("the reverse stock split"). After such reverse stock split, the authorized share capital of the Company were divided into 25,000,000 ordinary shares with par value of US$0.002 each, comprising of :1) 12,141,093 Class A ordinary shares with par value of US$0.002 each, 2) 2,858,908 Class B ordinary shares with par value of US$0.002 each, and 3) 9,999,999 shares of a par value of US$0.002 each of such class or classes (however designated) as the board of directors of the Company (the "Directors") may determine. The reverse stock split was effective on November 3, 2024.

All information related to the Company's ordinary shares, restricted stock units and stock options, as well as all per share data included in these financial statements and footnotes have been retrospectively adjusted to reflect the reverse stock split for all periods presented.

On November 13, 2023, the Company issued a total of 518,950 Class A ordinary shares, being the maximum aggregate number of shares which may be issued under the 2022 Share Incentive Plan (see Note 13) of the Company, to Nanoeco Ltd ("Nanoeco"), a British Virgin Islands limited liability company wholly owned by Kastle Limited, who has been designated as the nominee holder for the 518,950 Class A ordinary shares, which serves as the ESOP platform. During the six months ended June 30, 2025, a total of 3,811 options were exercised by employees at exercise price of US$0.002 per share.

On April 11, 2024, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain investors (collectively, the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors, in a private placement (the "Offering"), the Company's Class A ordinary shares at a purchase price of US$11.5 per share and warrants to purchase Class A ordinary shares. The warrants were exercisable immediately upon closing and have a term of exercise equal to five years. The Company issued an aggregate of 434,784 Class A ordinary shares and warrants to purchase 652,174 shares of Class A ordinary shares pursuant to the Purchase Agreement for gross proceeds of approximately US$5.0 million. The Company received all the net proceeds of approximately US$4.3 million (approximately RMB30.6 million) after deducting placement agent's fees and other offering expenses by April 16, 2024. During the six months ended June 30, 2025, several investors exercised warrants to purchase a total of 573,233 Class A ordinary shares at the exercise price of US$6.46 per share. The Company received the gross proceeds of approximately US$3.7 million (approximately RMB26.5 million) by June 30, 2025.

On February 21, 2025, the Company entered into Securities Purchase Agreements with certain investors (collectively, the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors, in a private placement, the Company's Class A ordinary shares at a purchase price of US$6.46 per share. The Company issued an aggregate of 913,714 Class A ordinary shares for gross proceeds of approximately US$5.9 million (approximately RMB42.4 million), which includes US$3.9 million in Bitcoin and US$2.0 million in USDT. The Company received all the gross proceeds by February 20, 2025.

On March 7, 2025, the shareholders of the Company approved to: 1) increase the authorized share capital from US$50,000 divided into 25,000,000 ordinary shares with par value of US$0.002 each to US$4,200,000 divided into 2,100,000,000 shares with a par value of US$0.002 each, comprising of 1,097,141,091 Class A ordinary shares, 2,858,909 Class B ordinary shares, and 1,000,000,000 shares of such class or classes (however designated) as the Directors may determine; and 2) increase the votes per Class B ordinary share from 15 to 30.

On June 27, 2025, the Company entered into Securities Purchase Agreements with certain investors (collectively, the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors, in a private placement (the "Offering"), the Company's Class A ordinary shares at a purchase price of US$8.40 per share and warrants to purchase Class A ordinary shares at an exercise price of US$10.00 per share (subject to adjustment for stock splits and the like). The warrants were exercisable immediately upon closing and have a term of exercise equal to five years. The Company issued an aggregate of 5,952,381 Class A ordinary shares and warrants to purchase 5,952,381 shares of Class A ordinary shares pursuant to the Purchase Agreement for gross proceeds of US$50.0 million. The Company received all the net proceeds of approximately US$46.1 million (approximately RMB330.5 million) after deducting placement agent's fees and other offering expenses by June 30, 2025.

As of December 31, 2024 and June 30, 2025, 458,453 and 454,642 Class A ordinary shares held by the ESOP platform are considered issued but not outstanding. As of December 31, 2024 and June 30, 2025, there were a total of 16,312,505 and 23,571,833 Class A and Class B ordinary shares issued, 15,674,052 and 23,117,191 Class A and Class B ordinary shares outstanding, respectively.

**13. Share-based compensation**

2022 Share Incentive Plan

In June 2022, our shareholders and board of directors adopted our 2022 share incentive plan, or the 2022 Plan, which has become effective upon the completion of our initial public offering, to motivate, attract and retain the best available personnel, provide additional incentives to employees, directors and consultants and promote the success of our business. Under the 2022 Plan, the maximum aggregate number of Class A ordinary shares which may be issued pursuant to all awards under such plan is 518,950, which constitutes 10 % of the total issued and outstanding shares of our company on a fully-diluted basis as of the date of adoption.

Restricted Stock Units ("RSUs")

On November 1, 2021, the Board of the Company approved the establishment of an employee benefit trust for the purpose of holding the Company's ordinary shares to be transferred to the recipient employees and directors of the share awards granted prior to the establishment of the 2022 Plan. In January 2022, Mr. Jianping Kong and other original shareholders of Zhejiang Haowei transferred a total of 562,668 ordinary shares held by them on behalf of the respective equity reward holders to Nanometa Ltd. ("Nanometa"), the nominee of the employee benefit trust. 187,334 shares held by Nanometa were transferred to the recipient employees and directors. As of June 30, 2025, a total of 375,334 shares were still held by Nanometa, which comprises of: 1) 349,669 shares held on behalf of and transferable to the recipient employees and directors upon request; 2) 25,665 shares unassigned due to forfeiture of share awards.

During the six months ended June 30, 2024 and 2025, share-based compensation recognized by the Company related to the RSUs were RMB235 and nil, respectively. As of December 31, 2024 and June 30, 2025, unrecognized compensation cost is nil.

Options

On April 27, 2023, the Company granted a series of options under the 2022 share incentive plan: 1) the Company granted employees options to purchase a total of 22,522 Class A ordinary shares of the Company with an exercise price of US$0.002 per share. The options granted have a contractual term of 10 years. For the reward, 33.3% will be vested on April 27, 2024; 33.3% will be vested on April 27, 2025; and 33.3% will be vested on April 27, 2026; 2) the Company granted employees options to purchase a total of 7,787 Class A ordinary shares of the Company with an exercise price of US$0.002 per share. The options granted have a contractual term of 10 years. For the reward, 33.3% will be vested on July 12, 2023; 33.3% will be vested on July 12, 2024; and 33.3% will be vested on July 12, 2025; 3) the Company also granted employees options to purchase a total of 54,579 Class A ordinary shares of the Company with an exercise price of US$0.002 per share. The options granted have a contractual term of 10 years. The options were fully vested and exercisable at the grant date. The options in 1) and 2) described above were subject to performance conditions based on the result of an annual performance review of the grantee in accordance with the predetermined performance targets. The Company estimated the annual performance review result for each grantee and recognized the related compensation expenses.

On August 16, 2023, under the 2022 plan, the Company granted an employee an option to purchase 1,299 ordinary shares of the Company with an exercise price of US$0.002 per share. The options granted have a contractual term of 10 years. For the reward, 33.3% will be vested on August 16, 2023; 33.3% will be vested on August 16, 2024; and 33.3% will be vested on August 16, 2025.

The following table summarizes the share option activity and related information for the six months ended June 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Number of<br> Options** | **Weighted<br> Average<br> Exercise<br> Price<br> (RMB)** | **Weighted<br> Average<br> Remaining<br> Term<br> (Years)** | **Weighted<br> Average<br> Grant Date<br> Fair Value<br> (RMB)** | **Aggregated<br> Intrinsic<br> Value<br> (RMB)** |
| Outstanding as of January 1, 2025 | 16157 | 0.01 | 8.3 | 73.4 | 1039402 |
| Granted |  |  |  |  |  |
| Forfeited | 1728 | 0.01 |  | 73.4 |  |
| Exercised | 3811 | 0.01 |  | 73.4 |  |
| Outstanding as of June 30, 2025 | 10618 | 0.01 | 7.8 | 73.4 | 705214 |
| Vested and exercisable as of June 30, 2025 | 5296 | 0.01 | 7.8 | 73.4 | 351698 |

---

During the six months ended June 30, 2024 and 2025, share-based compensation recognized by the Company related to the options were RMB285,272 and RMB62,337 respectively. The outstanding unamortized share-based compensation related to options was RMB84,677 (which will be recognized through April 2026) as of June 30, 2025.

**14. Statutory Reserves**

The Company's subsidiaries incorporated in the PRC are required on an annual basis to make appropriations of retained earnings set at certain percentage of after-tax profit determined in accordance with PRC accounting standards and regulations ("PRC GAAP").

Appropriation to the statutory general reserve should be at least 10% of the after tax net income determined in accordance with the legal requirements in the PRC until the reserve is equal to 50% of the entities' registered capital. The Company is not required to make appropriation to other reserve funds and the Company does not have any intentions to make appropriations to any other reserve funds.

The general reserve fund can only be used for specific purposes, such as offsetting the accumulated losses, enterprise expansion or increasing the registered capital. Appropriations to the general reserve funds are classified in the unaudited consolidated balance sheets as statutory reserves.

There are no legal requirements in the PRC to fund these reserves by transfer of cash to restricted accounts, and the Company has not done so.

Relevant laws and regulations permit payments of dividends by the PRC subsidiaries and affiliated companies only out of their retained earnings, if any, as determined in accordance with respective accounting standards and regulations. Accordingly, the above balances are not allowed to be transferred to the Company in terms of cash dividends, loans or advances.

The Company has made nil appropriations to statutory reserve for the six months ended June 30, 2024 and 2025.

**15. Income Taxes**

*Cayman Islands*

Under the current tax laws of Cayman Islands, the holding companies incorporated in the Cayman Islands are not subject to income, corporation or capital gains tax, and no withholding tax is imposed upon the payment of dividends.

*British Virgin Islands*

The holding companies incorporated in the British Virgin Islands are not subject to tax on income or capital gains under current British Virgin Islands law. In addition, upon payments of dividends by these entity to the shareholders, no British Virgin Islands withholding tax will be imposed.

*Hong Kong*

The Company' subsidiaries incorporated in Hong Kong are subject to Hong Kong Profits Tax on the taxable income as reported in its statutory financial statements adjusted in accordance with relevant Hong Kong tax laws. The applicable tax rate is 8.25% on assessable profits arising in or derived from Hong Kong up to HKD2,000,000 and 16.5% on any part of assessable profits over HKD2,000,000. These companies did not make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned in Hong Kong since inception.

*United States ("US")*

 

The Company's subsidiary in the US is subject to profits tax at 21% statutory tax rate with respect to the profit generated from the US. The company did not make any provisions for the US profit tax as there were no assessable profits derived from or earned in the US since inception.

 

*Singapore*

The company incorporated in Singapore is subject to Singapore Profits Tax on the taxable income as reported in its statutory financial statements adjusted in accordance with relevant Singapore tax laws. The applicable tax rate is 17% in Singapore, with 75% of the first SGD100,000 (approximately RMB470,000) and 50% of the next SGD100,000 (approximately RMB470,000) taxable income exempted from income tax. The company did not make any provisions for Singapore income tax as there were no assessable profits derived from or earned in Singapore since inception.

*PRC*

The Company's subsidiaries incorporated in the PRC are subject to PRC Enterprise Income Tax ("EIT") on the taxable income in accordance with the relevant PRC income tax laws. A new enterprise income tax law (the "EIT Law") in the PRC was enacted and became effective on January 1, 2008. The EIT Law applies a uniform 25% enterprise income tax ("EIT") rate to both foreign invested enterprises and domestic enterprises. Accordingly, the Company's PRC subsidiaries are subject to the EIT rate of 25%. EIT grants preferential tax treatment to certain High and New Technology Enterprises ("HNTEs"). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. Zhejiang Nanomicro obtained the "high-tech enterprise" tax status in December 2021 and renewed the status in December 2024, which reduced its statutory income tax rate to 15% from December 2021 to December 2027. Zhejiang Weike obtained the "high-tech enterprise" tax status in December 2023, which reduced its statutory income tax rate to 15% from December 2023 to December 2026.

The provision for income taxes consists of the following:

---

| | | |
|:---|:---|:---|
|  | **For the<br> six months<br> ended<br> June 30,<br> 2024** | **For the<br> six months<br> ended<br> June 30,<br> 2025** |
|  | **(Unaudited)** | **(Unaudited)** |
|  | **RMB** | **RMB** |
| Current income tax expense |  |  |
| Deferred tax expense |  |  |
| Income tax expense |  |  |

---

The effective tax rate was 0.00% for the six months ended June 30, 2024 and 2025.

**16. Concentrations**

The following table sets forth information as to each customer that accounted for 10% or more of the Company's revenues for the six months ended June 30, 2024 and 2025:

---

| | | |
|:---|:---|:---|
|  | **For the six months ended<br> June 30,** | **For the six months ended<br> June 30,** |
|  | **2024** | **2025** |
|  | **(Unaudited)** | **(Unaudited)** |
| Customer A | 17.2% | 35.4% |
| Customer B |  | 15.5% |
| Customer C |  | 14.6% |
| Customer D | 13.7% |  |
| Customer E | 12.8% |  |

---

The following table sets forth information as to each supplier that accounted for 10% or more of the Company's purchase for the six months ended June 30, 2024 and 2025:

---

| | | |
|:---|:---|:---|
|  | **For the six months ended<br> June 30,** | **For the six months ended<br> June 30,** |
|  | **2024** | **2025** |
|  | **(Unaudited)** | **(Unaudited)** |
| Supplier A |  | 39.0% |
| Supplier B |  | 14.2% |
| Supplier C |  | 13.2% |
| Supplier D | 15.7% | 12.7% |
| Supplier E | 11.5% |  |
| Supplier F | 11.2% |  |
| Supplier G | 10.5% |  |
| Supplier H | 20.4% |  |

---

**17. Commitments and contingencies**

*Operating lease commitments*

The information of lease commitments is provided in Note 9.

*Contingencies*

The Company is subject to litigation matters from time to time in the normal cause of business. The Company's legal counsel and the management routinely assess the likelihood of adverse judgments and outcomes to these matters, as well as ranges of probable losses. Accruals are recorded for these matters to the extent that management concludes a loss is probable and the financial impact, should an adverse outcome occur, is reasonable estimable. The Company has not recorded any material liabilities in this regard as of December 31, 2024 and June 30, 2025.

On March 5, 2024, a customer filed a civil action against one of the Company's subsidiaries at the People's Court of Shangcheng District, Hangzhou City ("the Court"), for a sales contract dispute, claiming the contract should be annulled and demanding a return of payment of RMB2,973,600 with related interests. In July 2025, the Court dismissed the plaintiff's claim in the first instance and the customer appealed a second instance to the Court. Given the nature of the case, as of this filing date, the amount liable by the Company in the event of an unfavorable outcome cannot be reasonably estimated.

The Company believes they have strong arguments against this claim and will defend vigorously.

One bank account of the Company was judicially frozen by the court as a result of legal proceedings. The frozen amount as of June 30, 2025 and this filing date was RMB468,526 and nil, respectively.

**18. Subsequent events**

Except as set forth below, there were no events that occurred subsequent to June 30, 2025 that require adjustment to or disclosure in the unaudited consolidated financial statements.

In July 2025, the Company entered into two short-term loan agreements with Bank of Hangzhou Co., Ltd, both guaranteed by Mr. Jianping Kong and Haoweiverse, to borrow a total amount of RMB10.0 million to fund the Company's working capital. The borrowings bear an annual interest rate of 3.1% with maturity dates of January 23, 2026 and July 23, 2026.

In July 2025, the Company entered into a securities purchase agreement to purchase 495,050 shares and 495,050 stapled warrants of CEA industries, Inc. in a total subscription amount of approximately US$5.0 million paid in USDT.

On August 21, 2025, the Company entered into an at the market offering agreement (the "ATM Agreement") with Maxim Group LLC ("Maxim"), pursuant to which the Company may offer and sell its Class A ordinary shares from time to time through Maxim, acting as the Company's sales agent. The Company will pay Maxim as compensation a fixed commission rate of 2.5% of the gross proceeds of each sale of Class A ordinary shares. Pursuant to the registration statement filed registering shares to be sold in accordance with the terms of the ATM Agreement, the Company may offer and sell its Class A ordinary shares up to a maximum aggregate offering price of US$45,000,000.

From July to September 2025, the Company borrowed approximately RMB0.9 million in total from Zhejiang Shaoxing Ruifeng Rural Commercial Bank Co., Ltd under the credit line pledged by the land use right and property, plant and equipment of the Company as described in Note 11. The additional borrowings bear an annual interest rate of 5.4% with repayment date on July 25, 2030.

## Exhibit 99.2

**Exhibit 99.2**

**MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

 

*This management's discussion and analysis is designed to provide you with a narrative explanation of our financial condition and results of operations for the six months ended June 30, 2024 and 2025. This section should be read in conjunction with our unaudited consolidated financial statements and the related notes included elsewhere in this interim report. See "Exhibit 99.1—Unaudited Consolidated Financial Statements as of December 31, 2024 and June 30, 2025 and for the six months ended June 30, 2024 and 2025." We also recommend that you read our management's discussion and analysis and our audited consolidated financial statements for fiscal year 2024, and the notes thereto, which appear in our annual report on Form 20-F for the year ended December 31, 2024, or the Annual Report, filed with the U.S. Securities and Exchange Commission, or the SEC, on April 11, 2025.*

 

*Unless otherwise indicated or the context otherwise requires, all references to "our company," "we," "our," "ours," "us" or similar terms refer to Nano Labs Ltd and its subsidiaries. All references to "China" or "PRC" refer to the People's Republic of China. All references to "RMB" or "Renminbi" refer to the legal currency of China. All references to "US$," "U.S. dollars," "$" or "dollars" refer to the legal currency of the United States of America.*

 

*All such financial statements were prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. We have made rounding adjustments to some of the figures included in this management's discussion and analysis. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that precede them. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors.*

**Overview**

We are a leading Web 3.0 infrastructure and product solution provider, specialized in the development of HTC chips and HPC chips. We have built a comprehensive FPU architecture which offers solution that integrates the features of both HTC and HPC. In addition, we have actively positioned ourselves in the digital assets space, starting to adopt BNB as our primary reserve asset in July 2025. As of September 16, 2025, we have accumulated nearly US$122.2 million in BNB and US$70.0 million in BTC.

Our net operating revenues are primarily derived from sales of our HTC and HPC solutions and provision of design and technical services to our customers. Our net revenues were RMB24.7 million and RMB8.3 million (US$1.2 million) for the six months ended June 30, 2024 and 2025, respectively. The decrease in net revenues was primarily due to the drop of sales volume of iPollo V Series. We recorded a net loss of RMB59.1 million and RMB11.8 million (US$1.6 million) for the six months ended June 30, 2024 and 2025, respectively.

In evaluating our business, we consider and use adjusted net loss as an additional non-GAAP measure to review and assess our operating performance. The presentation of the non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. We define adjusted net loss as net loss excluding share-based compensation expense. Our adjusted net loss for the six months ended June 30, 2024 was RMB58.9 million, and our adjusted net loss for the same period of 2025 was RMB11.7 million (US$1.6 million).

**Results of Operations**

The following table sets forth a summary of our unaudited consolidated statements of operations for the periods indicated. This information has been derived from and should be read together with our unaudited consolidated financial statements. The results of operations in any period are not necessarily indicative of the results that may be expected for any future period.

---

| | | | |
|:---|:---|:---|:---|
|  | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Summary Unaudited Consolidated Statements of Operations and Comprehensive Loss |  |  |  |
| Net Revenues | 24739480 | 8283373 | 1157122 |
| Cost of revenues | 24709417 | 18991737 | 2652996 |
| Gross profit (loss) | 30063 | (10708364) | (1495874) |
| Total operating expenses | 58722004 | 27325290 | 3817128 |
| Net loss | (59145670) | (11777937) | (1645286) |
| Net loss per ordinary share attributable to Nano Labs Ltd |  |  |  |
| Basic and diluted\* | (8.46) | (0.43) | (0.06) |
| Weighted average number of shares used in per share calculation |  |  |  |
| Basic and diluted\* | 6766671 | 16548783 | 16548783 |

---

\* After giving effect of the 10-for-1 reverse stock split effective on November 3, 2024.

**Non-GAAP Financial Measures**

To supplement our unaudited consolidated financial statements which are presented in accordance with U.S. GAAP, we also use adjusted net loss as an additional non-GAAP financial measure. We present the non-GAAP financial measure because it is used by our management to evaluate our operating performance. We also believe that the non-GAAP financial measure provides useful information to investors and others in understanding and evaluating our consolidated results of operations in the same manner as our management and in comparing financial results across accounting periods and to those of our peer companies.

We define adjusted net loss as net loss excluding share-based compensation expense. We believe that adjusted net loss provides useful information to investors and others in understanding and evaluating our operating results. The non-GAAP financial measure adjusts for the impact of items that we do not consider indicative of the operational performance of our business and should not be considered in isolation or construed as an alternative to net loss or any other measure of performance or as an indicator of our operating performance. Investors are encouraged to compare the historical non-GAAP financial measure with the most directly comparable GAAP measures.

Adjusted net loss presented here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. We encourage investors and others to review our financial information in its entirety and not rely on a single financial measure.

The following table sets forth a reconciliation of our net loss to non-GAAP adjusted net loss for the periods indicated.

---

| | | | |
|:---|:---|:---|:---|
|  | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **Net loss** | **(59145670)** | **(11777937)** | **(1645286)** |
| Add: |  |  |  |
| Share-based compensation expenses | 285507 | 62337 | 8708 |
| **Non-GAAP adjusted net loss** | **(58860163)** | **(11715600)** | **(1636578)** |

---

**Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024**

 ****

***Net Revenues***

Our net revenues are primarily derived from sales of our HTC and HPC solutions and provision of design and technical services to our customers. The following table sets forth the breakdown of our net revenues by category, both in absolute amount and as a percentage of total net revenues for each category for the periods indicated.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** |
|  | **2024** | **2024** | **2025** | **2025** | **2025** |
|  | **RMB** | **%** | **RMB** | **US$** | **%** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Product sales revenue | 20352715 | 82.3 | 7931032 | 1107903 | 95.7 |
| Service revenue | 4386765 | 17.7 | 352341 | 49219 | 4.3 |
| **Net revenues** | **24739480** | **100.0** | **8283373** | **1157122** | **100.0** |

---

 ****

*Product sales revenue*

Our product sales revenue primarily comprises sales of our HTC solutions in relation to ETC and Grin mining, and distributed computing and data storage solutions for Filecoin mining. Our product sales revenue decreased from RMB20.4 million for the six months ended June 30, 2024 to RMB7.9 million (US$1.1 million) for the six months ended June 30, 2025, primarily due to the drop of sales volume of iPollo V Series.

*Service revenue*

Service revenue primarily includes revenues from the provision of design and technical services to our customers. Our service revenue decreased from RMB4.4 million for the six months ended June 30, 2024 to RMB0.4 million (US$0.05 million) for the six months ended June 30, 2025, mainly due to the downsize of research and development department that provides related services.

***Cost of Revenues***

Cost of revenues represent costs and expenses incurred in order to generate revenue. Cost of revenues mainly consist of products costs, including costs of raw material, contract manufacturers for production, testing costs, slow-moving and obsolete inventories write-downs, prepayments write-downs, value-added tax recoverable write-downs, and staff costs for our employees involved in the provision of services.

The following table sets forth the breakdown of our cost of revenues by category, both in absolute amount and as a percentage of the cost of revenues, for the periods indicated.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** |
|  | **2024** | **2024** | **2025** | **2025** | **2025** |
|  | **RMB** | **%** | **RMB** | **US$** | **%** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Product sales | 22065194 | 89.3 | 18793438 | 2625295 | 99 |
| Service | 2644223 | 10.7 | 198299 | 27701 | 1 |
| **Total** | **24709417** | **100.0** | **18991737** | **2652996** | **100.0** |

---

Cost of revenues decreased to RMB19.0 million (US$2.7 million) for the six months ended June 30, 2025 from RMB24.7 million for the same period of 2024. The decrease in cost of sales was mainly due to the decrease in the sales volume of our products and write-down of inventory and value-added tax recoverable.

 ****

***Gross Profit (Loss)***

The following table sets forth our gross profit (loss) and gross profit (loss) margin by category for the periods indicated.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** | **For the six months ended June 30,** |
|  | **2024** | **2024** | **2025** | **2025** | **2025** |
|  | **RMB** | **Gross Profit (Loss) <br> Margin (%)** | **RMB** | **US$** | **Gross Profit (Loss) <br> Margin (%)** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Product sales | (1712479) | (8.4) | (10862406) | (1517392) | (137.0) |
| Service | 1742542 | 39.7 | 154042 | 21518 | 43.7 |
| **Total** | **30063** | **0.1** | **(10708364)** | **(1495874)** | **(129.3)** |

---

As a result, we recorded a gross loss of RMB10.7 million (US$1.5 million) for the six months ended June 30, 2025, as compared to a gross profit of RMB30.1 thousand for the same period of 2024.

 ****

***Operating Expenses***

Total operating expenses decreased to RMB27.3 million (US$3.8 million) for the six months ended June 30, 2025, from RMB58.7 million for the same period of 2024.

● Selling and marketing expenses decreased by 39.6% to RMB2.6 million (US$0.4 million) for the six months ended June 30, 2025, from RMB4.3 million for the same period of 2024. The decrease in selling and marketing expenses was primarily due to the decrease in sales commission and salaries.

● General and administrative expenses decreased by 15.4% to RMB21.5 million (US$3.0 million) for the six months ended June 30, 2025, from RMB25.5 million for the same period of 2024. The decrease in general and administrative expenses was primarily due to the decrease in professional fees and employee salary expenses.

● Research and development expenses decreased by 89.1% to RMB3.2 million (US$0.4 million) for the six months ended June 30, 2025, from RMB28.9 million for the same period of 2024. The decrease in research and development expenses, including mainly salary expenses, design fee, service fee and material cost, was primarily due to the strategic adjustment in research and development activities in 2025.

 **

***Finance Expense (Income)***

 **

We recorded a finance expense of RMB0.3 million (US$0.04 million) for the six months ended June 30, 2025, as compared to a finance income of RMB0.6 million for the same period of 2024.

***Interest Expense***

 ****

Interest expense was RMB5.3 million (US$0.7 million) for the six months ended June 30, 2025, compared to RMB2.0 million for the same period of 2024. The change was mainly due to the completion of construction in progress and cease of interest capitalization in April 2024, as well as increase in short-term borrowings during the six months ended June 30, 2025.

***Change in Fair Value of Cryptocurrencies***

 ****

Change in fair value of cryptocurrencies was a gain of RMB48.6 million (US$6.8 million) for the six months ended June 30, 2025, compared to nil for the same period of 2024. The change was due to the cryptocurrency holding strategy the Company developed at the end of 2024.

***Change in Fair Value of Convertible Notes***

 ****

Change in fair value of convertible notes was a loss of RMB18.5 million (US$2.6 million) for the six months ended June 30, 2025, compared to nil for the same period of 2024. The change was due to the issuance of convertible bonds denominated in Bitcoin in 2025, which was measured at fair value on June 30, 2025.

 ****

***Net Loss***

Net loss decreased by 80.1% to RMB11.8 million (US$1.6 million) for the six months ended June 30, 2025 from RMB59.1 million for the same period of 2024.

Basic and diluted loss per share attributable to Nano Labs Ltd was RMB0.43 (US$0.06) for the six months ended June 30, 2025, decreased from RMB8.46 for the same period of 2024.

**Liquidity and Capital Resources**

Our primary source of liquidity historically has been cash generated from our business operations, equity contributions from our shareholders and borrowings, which have historically been sufficient to meet our working capital and capital expenditure requirements.

As of December 31, 2024 and June 30, 2025, we had RMB32.4 million and RMB363.4 million (US$50.8 million) in cash and cash equivalents, respectively. Our cash and cash equivalents primarily consist of cash in bank and highly liquid investments placed with banks, which are unrestricted to withdrawal and use and have original maturities of less than three months.

In August 2022, we were granted a credit line of up to RMB100 million from a commercial bank with a mortgage of our 50-year right to use a parcel of land with an area of 49,452 square meters located in Shaoxing, China. In June 2023, the credit line was increased to a maximum amount of RMB148 million, with guarantee provided by Mr. Jianping Kong, the principal shareholder, chairman and chief executive officer starting from July 2023. In April 2024, the credit line was increased to a maximum amount of RMB198 million, with additional pledge by our buildings with area of 123,507 square meters located in Shaoxing, China. As of the date of this report, we have a balance of borrowing of approximately RMB180.2 million (US$25.2 million) under the credit line.

We believe that our existing cash and cash equivalents will be sufficient to meet our anticipated cash needs for general corporate purposes for the next 12 months from the date of this interim report. However, the exact amount of proceeds we use for our operations and expansion plans will depend on the amount of cash generated from our operations and any strategic decisions we may make that could alter our expansion plans and the amount of cash necessary to fund these plans. We may, however, decide to enhance our liquidity position or increase our cash reserve for future investments through additional capital and finance funding. We may need additional cash resources in the future if we experience changes in business conditions or other developments, or if we find and wish to pursue opportunities for investments, acquisitions, capital expenditures or similar actions. If we determine that our cash requirements exceed the amount of cash and cash equivalents we have on hand at the time, we may seek to issue equity or debt securities or obtain credit facilities. The issuance and sale of additional equity would result in further dilution to our shareholders. The incurrence of indebtedness would result in increased fixed obligations and could result in operating covenants that would restrict our operations. We cannot assure you that financing will be available in amounts or on terms acceptable to us, if at all.

Our ability to manage our working capital, including receivables and other assets and liabilities and accrued liabilities, may materially affect our financial condition and results of operations.

The following table sets forth our selected consolidated cash flow data for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
|  | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2024** | **2025** | **2025** |
|  | **RMB** | **RMB** | **US$** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Net cash used in operating activities | (76754346) | (50782563) | (7093923) |
| Net cash provided by (used in) investing activities | (32935838) | 7386082 | 1031778 |
| Net cash provided by financing activities | 80179082 | 375865745 | 52505482 |
| Effect of exchange rate on cash, cash equivalents and restricted cash | 4853211 | (1410129) | (196986) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | (24657891) | 331059135 | 46246351 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 48582654 | 32849803 | 4588859 |
| Cash, cash equivalents and restricted cash at the end of the period | 23924763 | 363908938 | 50835210 |

---

***Operating Activities***

Net cash used in operating activities for the six months ended June 30, 2025 was RMB50.8 million (US$7.1 million), which primarily reflected our net loss of RMB11.8 million (US$1.6 million) as mainly adjusted for (1) Gain from change in fair value of cryptocurrencies of RMB48.6 million (US$6.8 million), (2) Loss from change in fair value of convertible notes of RMB18.5 million (US$2.6 million), (3) inventory write-down of RMB5.7 million (US$0.8 million), which was primarily due to the downward adjustment on the book value of a portion of our inventories, (4) depreciation and amortization expenses of RMB5.5 million (US$0.8 million), and changes in working capitals. Adjustment for changes in working capital primarily consisted of (1) decrease in other current liabilities of RMB14.1 million (US$2.0 million), (2) increase in inventories of RMB11.7 million (US$1.6 million), (3) increase in prepayments of RMB4.1 million (US$0.6 million), and (4) decrease in advance from customers of RMB3.3 million (US$0.5 million), partially offset by (1) increase in accounts payable of RMB8.7 million (US$1.2 million) and (2) decrease in other current assets of RMB4.2 million (US$0.6 million).

Net cash used in operating activities for the six months ended June 30, 2024 was RMB76.8 million, which primarily reflected our net loss of RMB59.1 million as mainly adjusted for (1) inventory write-down of RMB12.4 million, which was primarily due to the downward adjustment on the book value of a portion of our inventories, (2) depreciation and amortization expenses of RMB3.2 million, (3) amortization of right-of-use assets of RMB2.2 million and (4) changes in working capitals. Adjustment for changes in working capital primarily consisted of (1) increase in other current assets of RMB10.9 million, (2) decrease in other current liabilities of RMB10.8 million, (3) increase in inventories of RMB8.3 million, (4) decrease in advance from customers of RMB6.7 million, (5) decrease in operating lease liabilities of RMB2.3 million, partially offset by (1) decrease in accounts receivable of RMB1.3 million, (2) increase in accounts payable of RMB1.2 million and (3) decrease in prepayments of RMB0.6 million.

***Investing Activities***

Net cash provided by investing activities for the six months ended June 30, 2025 was RMB7.4 million (US$1.0 million), mainly attributable to (1) the proceeds from disposal of cryptocurrencies of RMB7.9 million (US$1.1 million) and (2) the proceeds from disposal of property, plant and equipment of RMB2.1 million (US$0.3 million), partially offset by the purchase of investment of RMB2.0 million (US$0.3 million).

Net cash used in investing activities for the six months ended June 30, 2024 was RMB32.9 million, attributable to the purchases of property, plant and equipment of RMB32.9 million.

***Financing Activities***

Net cash generated from financing activities for the six months ended June 30, 2025 was RMB375.9 million (US$52.5 million), mainly attributable to (1) the proceeds from issuance of ordinary shares and warrants of RMB357.0 million (US$49.9 million) and (2) proceeds from bank loans of RMB21.2 million (US$3.0 million), partially offset by repayments of bank loans of RMB2.7 million (US$0.4 million).

Net cash generated from financing activities for the six months ended June 30, 2024 was RMB80.2 million, mainly attributable to (1) proceeds from bank loans of RMB185.3 million, (2) the proceeds from issuance of ordinary shares of RMB30.6 million and (3) cash contribution from a noncontrolling shareholder of RMB10.0 million, partially offset by repayments of bank loans of RMB145.7 million.

**Capital Expenditures**

We incurred capital expenditures of RMB32.9 million and RMB0.6 million (US$0.1 million) for the six months ended June 30, 2024 and 2025, respectively. In these periods, our capital expenditures were mainly used for construction of plant for the expansion and optimization of our supply chain.

We plan to fund our future capital expenditures with our existing cash balance and proceeds from the securities offering. We will continue to make capital expenditures to meet the expected growth of our business, including for procurement of photomask, mold and various intellectual properties.

**Off-Balance Sheet Arrangements**

We have not entered into any off-balance sheet financial guarantees or other off-balance sheet commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder's equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or product development services with us.

**Critical Accounting Policies and Estimates** 

An accounting policy is considered critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time such estimate is made, and if different accounting estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the consolidated financial statements.

We prepare our financial statements in conformity with the U.S. GAAP, which requires us to make judgments, estimates and assumptions. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical experiences and various other assumptions that we believe to be reasonable under the circumstances. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from our expectations as a result of changes in our estimates. We have determined that we have no critical accounting policies and estimates during the six months ended June 30, 2025.

**Cautionary Statement Regarding Forward-Looking Statements**

We have made statements in this report that constitute forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "should," "could" and similar expressions. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements.

These forward-looking statements include statements about:

The ultimate correctness of these forward-looking statements depends upon a number of known and unknown risks and events. Many factors could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Consequently, you should not place undue reliance on these forward-looking statements.

The forward-looking statements speak only as of the date on which they are made; and, except as required by law we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The forward-looking statements included in this report relate to, among others:

● our goals and strategies;

● our business and operating strategies and plans for the development of existing and new businesses, ability to implement such strategies and plans and expected time;

● our future business development, results of operations and financial condition;

● expected changes in our revenue, costs or expenditures;

● our expectations regarding demand for and market acceptance of our products and services;

● our projected markets and growth in markets;

● our potential need for additional capital and the availability of such capital;

● competition in our industry;

● relevant government policies and regulations relating to our industry;

● general economic and business conditions in China and globally;

● our use of the proceeds;

● the length and severity of the COVID-19 pandemic and its impact on our business and industry; and

● assumptions underlying or related to any of the foregoing.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update this forward-looking information. Nonetheless, we reserve the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this interim report. No such update shall be deemed to indicate that other statements not addressed by such update remain correct or create an obligation to provide any other updates.